Skip to content
healthcare.dev

Tizanidine

NDC 51655-603, Tizanidine, tablet, from Northwind Health Company, LLC.

Product NDC
51655-603
Status
Listed
Labeler
Northwind Health Company, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA076286
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51655-603 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TIZANIDINE HYDROCHLORIDE4 mg/1

Pharmacologic classes

Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]

Package NDCNDC-11Package
51655-603-205165506032020 TABLET in 1 BOTTLE, PLASTIC (51655-603-20)
51655-603-265165506032690 TABLET in 1 BOTTLE, PLASTIC (51655-603-26)
51655-603-525165506035230 TABLET in 1 BOTTLE, PLASTIC (51655-603-52)
51655-603-545165506035415 TABLET in 1 BOTTLE, PLASTIC (51655-603-54)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/da31fbeb-3781-5e75-e053-2a95a90adb73

Use it

Look up 51655-603 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51655-603 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51655-603. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.